Furthermore, we determined that hepatic PGM5 expression had a modest diagnostic value for liver cancer overall and for each of the four stages of liver cancer, suggesting it has potential use as a novel diagnostic biomarker. The gene discussed is PGM5; the disease is liver cancer.